quinazolines has been researched along with methamphetamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, R; Kudo, Y; Ochiai, T; Yamamura, M | 1 |
| Bai, Y; Barak, LS; Caron, MG; Chung, TD; Evron, T; Hanson, GR; Hedrick, MP; Hershberger, P; Maloney, PR; Peddibhotla, S; Peterson, S; Pinkerton, AB; Rodriguiz, RM; Thomas, JB; Urs, NM; Wetsel, WC | 1 |
2 other study(ies) available for quinazolines and methamphetamine
| Article | Year |
|---|---|
[General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. I. Effects on the central nervous system (author's transl)].
Topics: Agonistic Behavior; Analgesics; Animals; Anticonvulsants; Avoidance Learning; Barbital; Body Temperature; Brain; Conditioning, Psychological; Drug Synergism; Hexobarbital; Male; Methamphetamine; Mice; Motor Activity; Muscle Relaxants, Central; Quinazolines; Rats; Rats, Inbred Strains; Reserpine | 1981 |
ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse.
Topics: Allosteric Regulation; Amphetamine-Related Disorders; Animals; Dopamine Plasma Membrane Transport Proteins; Ligands; Locomotion; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperazines; Quinazolines; Receptors, Neurotensin | 2016 |